NDC 63323-286-01 - NAROPIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-286
- Requested NDC
- 63323-286-01
- Package NDCs from labels
- 63323-286-51, 63323-286-55, 63323-286-41, 63323-286-27, 63323-286-43, 63323-286-38, 63323-286-01, 63323-286-20, 63323-286-05, 63323-286-23, 63323-286-09, 63323-286-31, 63323-286-11, 63323-286-35, 63323-286-03, 63323-286-00, 63323-286-33, 63323-286-63, 63323-286-30, 63323-286-93, 63323-286-95
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2026-07-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NAROPIN - Henry Schein, Inc. | Henry Schein, Inc. | 2026-07-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2026-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-08-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi Austria | HP Halden Pharma AS | Fresenius Kabi USA, LLC | Fresenius Kabi Austria | HP Halden Pharma AS | 2024-08-06 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-07-10 | HUMAN PRESCRIPTION DRUG LABEL |
| NAROPIN - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Naropin - APP Pharmaceuticals, LLC | Fresenius Kabi Norge AS | APP Pharmaceuticals, LLC | Fresenius Kabi Norge AS | 2011-09-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-286-00 | Naropin | 12 in 1 CASE | INJECTION, SOLUTION | 12 | 27 | |
| 63323-286-01 | Naropin | 20 mL in 1 AMPULE | INJECTION, SOLUTION | 20 | 27 | |
| 63323-286-03 | Naropin | 100 mL in 1 BOTTLE | INJECTION, SOLUTION | 100 | 27 | |
| 63323-286-05 | Naropin | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 27 | |
| 63323-286-09 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 27 | |
| 63323-286-11 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 27 | |
| 63323-286-20 | Naropin | 5 in 1 BOX | INJECTION, SOLUTION | 5 | 27 | |
| 63323-286-23 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 27 | |
| 63323-286-30 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 27 | |
| 63323-286-30 | Naropin | 1 in 1 BOX | INJECTION, SOLUTION | 1 | 27 | |
| 63323-286-31 | Naropin | 5 in 1 BOX | INJECTION, SOLUTION | 5 | 27 | |
| 63323-286-33 | Naropin | 200 mL in 1 BOTTLE | INJECTION, SOLUTION | 200 | 27 | |
| 63323-286-35 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 27 | |
| 63323-286-63 | Naropin | 12 in 1 CASE | INJECTION, SOLUTION | 12 | 27 | |
| 63323-286-93 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 8 | |
| 63323-286-95 | Naropin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 8 | |
| 63323-286-27 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 6 | |
| 63323-286-38 | Naropin | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 6 | |
| 63323-286-41 | Naropin | 20 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 20 | 6 | |
| 63323-286-43 | Naropin | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-286 | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 27 | Current NDC, Legacy NDC, 14 package rows | 20240814_23d2d448-a744-4877-9f2d-7e57c198da89.zip |
| 63323-286 | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 8 | Current NDC, Legacy NDC, 2 package rows | 20240817_c6613708-c1f7-4f5c-91a3-ebbc1d7905c6.zip |
| 63323-286 | NAROPIN (ROPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 6 | Current NDC, Legacy NDC, 4 package rows | 20240829_dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Psorinum Combination 9237 | PSORINUM COMBINATION | Professional Complementary Health Formulas | 8b2a133d-9681-4091-a6d1-4ecc4583626b | 2026-01-08 | Warnings | 451W47IQ8X |
| Endotoxin Terrain Drops 2143 | ENDOTOXIN TERRAIN DROPS | Professional Complementary Health Formulas | 58842566-005a-48b5-973d-20cde2fbd701 | 2026-01-08 | Warnings | QTT17582CB |
| Adrenal Liquescence 3001 | ADRENAL LIQUESCENCE | Professional Complementary Health Formulas | 0388d3c7-4b3b-4e74-8c1b-9a2af2a4377d | 2026-01-08 | Warnings | 451W47IQ8X |
| Anti-Constipation Drops 2077 | ANTI-CONSTIPATION DROPS | Professional Complementary Health Formulas | 55d105fe-5698-43a6-9252-eaa9b63299d0 | 2026-01-08 | Warnings | 451W47IQ8X |
| Anxious Drops 2098 | ANXIOUS DROPS | Professional Complementary Health Formulas | a5dc8619-074a-4c1f-8bb2-fea788f5aff1 | 2026-01-08 | Warnings | 451W47IQ8X |
| Spleen Thymus Liquescence 3023 | SPLEEN THYMUS LIQUESCENCE | Professional Complementary Health Formulas | abe3c5c4-c5b4-47dd-afe3-b7858c82f775 | 2026-01-08 | Warnings | 451W47IQ8X |
| RET Bladder 7006 | RET BLADDER | Professional Complementary Health Formulas | f1d354e7-3d72-40aa-aaf1-172cb39f0711 | 2026-01-08 | Warnings | 451W47IQ8X |
| Cataract Drops 2085 | CATARACT DROPS | Professional Complementary Health Formulas | 6040a096-ccdb-4e1e-a242-be29c3127f27 | 2026-01-08 | Warnings | 451W47IQ8X |
| Psorinum Miasm Drops 2054 | PSORINUM MIASM DROPS | Professional Complementary Health Formulas | a34aadab-b634-461f-a0ff-58f42f6e0833 | 2026-01-08 | Warnings | 451W47IQ8X |
| Opsin II 6015 | OPSIN II | Professional Complementary Health Formulas | 848d620e-ddd5-4787-a4bd-844be7615432 | 2026-01-08 | Warnings | 451W47IQ8X |
| Northwest Regional 1019 | NORTHWEST REGIONAL | Professional Complementary Health Formulas | 4dccc9f6-4d9e-4eec-b031-1fccdddb3d03 | 2026-01-08 | Warnings | 451W47IQ8X |
| Headache Drops 2027 | HEADACHE DROPS | Professional Complementary Health Formulas | a7e345fb-c4aa-4b10-8074-9d8c37304142 | 2026-01-08 | Warnings | 451W47IQ8X |
| Metab 6012 | METAB | Professional Complementary Health Formulas | f3576d6f-c9ab-4370-8a32-b6c4bf6ba4fd | 2026-01-08 | Warnings | 451W47IQ8X |
| Cell Salt Combination 8013 | CELL SALT COMBINATION | Professional Complementary Health Formulas | b3a33345-3c3d-4f86-ae4d-757c65fd1ed3 | 2026-01-08 | Warnings | 451W47IQ8X |
| Shingles Nosode 4028 | SHINGLES NOSODE | Professional Complementary Health Formulas | e71d917a-af9f-41e9-a3de-cb588db7e022 | 2026-01-08 | Warnings | 451W47IQ8X |
| Immune System Stimulator Drops 2033 | IMMUNE SYSTEM STIMULATOR DROPS | Professional Complementary Health Formulas | f4595c63-1c9c-48a6-a13a-3659991f455b | 2026-01-08 | Warnings | 451W47IQ8X |
| RET Gallbladder 7007 | RET GALLBLADDER | Professional Complementary Health Formulas | 82bc7b50-aea3-4993-b171-919940fef297 | 2026-01-08 | Warnings | 451W47IQ8X |
| Libido Stim Liquescence 3014 | LIBIDO STIM LIQUESCENCE | Professional Complementary Health Formulas | 3d59b77d-817b-4021-a6dd-75d3b4b60866 | 2026-01-08 | Warnings | 451W47IQ8X |
| RET Pituitary/Sex 7012 | RET PITUITARY/SEX | Professional Complementary Health Formulas | 5081185c-1598-4bf5-b47b-b15135c453fb | 2026-01-08 | Warnings | 451W47IQ8X |
| Abdominal Pain Drops 2051 | ABDOMINAL PAIN DROPS | Professional Complementary Health Formulas | f1b1dde6-bb37-4774-a58c-b4f648f9c2b5 | 2026-01-08 | Warnings | QTT17582CB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.